Bausch Health Companies Inc. (BHC) FY2026 Q2 P&L / Income Statement

Bausch Health Companies Inc. (BHC) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenues

2,852,000,000 US dollars

Cost of revenue (calculated)

772,000,000 US dollars

Gross profit (calculated)

2,080,000,000 US dollars

Operating expenses (calculated)

1,340,000,000 US dollars

Operating income (loss)

740,000,000 US dollars

Other income (expense), net (calculated)

negative 392,000,000 US dollars

Income (loss) before income taxes

348,000,000 US dollars

Provision for income taxes

88,000,000 US dollars

Net income (loss)

260,000,000 US dollars

Salix

758,000,000 US dollars

International

305,000,000 US dollars

Solta Medical

176,000,000 US dollars

Diversified

219,000,000 US dollars

Bausch + Lomb

1,394,000,000 US dollars

Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues

772,000,000 US dollars

Selling, general and administrative

907,000,000 US dollars

Research and development

173,000,000 US dollars

Amortization of intangible assets

225,000,000 US dollars

Goodwill impairments

0 US dollars

Restructuring, integration and separation costs

9,000,000 US dollars

Other expense (income), net

26,000,000 US dollars

Salix costs (calculated)

153,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

International costs (calculated)

215,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Solta Medical costs (calculated)

85,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Diversified costs (calculated)

77,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Bausch + Lomb costs (calculated)

1,059,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Reconciling items (calculated)

523,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to Bausch Health Companies Inc.: $258.00 M; to noncontrolling interests: $2.00 M.